SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017835
Filing Date
2023-05-04
Accepted
2023-05-04 16:06:16
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20230331.htm   iXBRL 10-Q 2521093
2 EX-31.1 mrus-ex31_1.htm EX-31 21059
3 EX-32.1 mrus-ex32_1.htm EX-32 12892
  Complete submission text file 0000950170-23-017835.txt   8076474

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrus-20230331_def.xml EX-101.DEF 161859
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrus-20230331_lab.xml EX-101.LAB 348879
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrus-20230331.xsd EX-101.SCH 42570
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrus-20230331_cal.xml EX-101.CAL 48930
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrus-20230331_pre.xml EX-101.PRE 252088
47 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20230331_htm.xml XML 1567407
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 23888640
SIC: 2834 Pharmaceutical Preparations